To include your compound in the COVID-19 Resource Center, submit it here.

TLN-4601: Phase II started

Thallion began an open-label, North American Phase II trial

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE